skip to the main content area of this page

Drug Laws/Individual Listing for INDONESIA

Drug Laws/Individual Listing
Ministry of Health, Regulation 05 of 2020 amending the Law No.35 of 2009 on Narcotics (in)
The list of controlled substances in Indonesia is included in Law No 35 of 2009, which is divided into three schedules, Type I (Golongan Satu), Type II (Golongan Dua), and Type III (Golongan Tiga), based on their addictive potential, with Type I regarded as having the highest possibilities of resulting in severe addiction. In March 2014, the Minister of Health Regulation No. 13 of 2014, amended the list of narcotics, by adding 18 NPS. These include phenethylamines (5- and 6-APB, 25B-NBOMe, 25C-NBOMe, 25I-NBOMe, PMMA), synthetic cannabinoids (JWH-018, XLR-11), synthetic cathinones (MDPV, mephedrone, methylone, MPHP, pentedrone)In 2020, the Minister of Health Regulation No. 5 of 2020, further updated the list of narcotics with 7 additional NPS. The newly added substances, MDMB-FUBINACA, AMB-FUBICA, 4F-MDMB-BINACA, 5F-MN-24, 5F-EMB-PINACA, 5F-EDMB-PINACA and 5F-MMB-PICA, are all synthetic cannabinoids.
Information on the NPS legislation:
National list of controlled NPS:

If you have any further information or any amendments to the information provided on this page, please send an email to Global SMART (